This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, November 30, 2012
December Hepatitis C Newsletter - AASLD 2012 Part 1: HCV Therapies
No comments:
Post a Comment